They were melanogenesis, thyroid cancer, bladder cancer, P53 signaling pathway, glycosphingolipid biosynthesis, renal cell carcinoma, basal cell carcinoma, and endometrial cancer. This evidence concerns the gene TP53 and renal cell carcinoma.